Atropine Sulfate Injection, Solution
Product Images NDC 70518-4188

Product Visual Gallery

This gallery contains 3 technical images submitted to the FDA as part of the official labeling for Atropine Sulfate (NDC 70518-4188). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Remedyrepack Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Mm2 (Atropine Sulfate 8mg 20ml(0.4mg mL) 70518 4188 01)

This is a vial of Atropine Sulfate injection containing 8mg/20mL (0.4mg/mL). It is meant for single use. It should be stored between 20° to 25°C (68 to 77°F) after the initial use and discarded within 24 hours. The medication must be kept out of reach of children and should be used as directed. The manufacturer is Fresenius Kabi located in Lake Zurich, IL, and it is repackaged by RemedyRepack Inc., Indiana, PA. Please refer to the package insert for further instructions on usage.*

FDA Label Image

Remedy_label (Remedy Label)

This is a description of Atropine Sulfate, a prescription medication used in injections. Each vial contains 8mg/20mL (0.4mg/mL) of the solution and is manufactured by Fresenius Kabi in Lake Zurich, IL. The medication should be stored between 20° to 25°C (68° to 77°F) after initial use and must be discarded within 24 hours. It comes in a pack of 10 vials and should be kept out of reach of children. The RemedyRepack Inc. has repackaged the medication in Indiana, PA. For detailed usage instructions, refer to the package insert.*

FDA Label Image

Structure (Atropine Structure)

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.